Board Meeting24 Jul 2026, 07:01 pm
Onesource Specialty Pharma Declares Unaudited Q1 FY27 Results
AI Summary
Onesource Specialty Pharma Ltd announced the outcome of its Board meeting held on July 24, 2026. The Board approved the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026. The results were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) and reviewed by statutory auditors, Deloitte Haskins & Sells. The meeting commenced at 16:30 hrs IST and concluded at 17:50 hrs IST.
Key Highlights
- Board meeting held on July 24, 2026, approved financial results.
- Unaudited financial results for the quarter ended June 30, 2026, were declared.
- Both standalone and consolidated results were approved.
- Limited review report from statutory auditors is enclosed.
Price Impact
More from ONESOURCE